Where does Loewenstein Medical Technology S.A. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Loewenstein Medical Technology S.A. ranks #4,568 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Loewenstein Medical Technology S.A. hold?

Loewenstein Medical Technology S.A. holds 77 US utility patents granted between 2017 and 2025, spanning 24 technology areas.

What is Loewenstein Medical Technology S.A.'s Innovation Score?

Loewenstein Medical Technology S.A. has an Innovation Score of 58.6 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Loewenstein Medical Technology S.A.'s patent grant rate increasing or decreasing?

Loewenstein Medical Technology S.A.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Loewenstein Medical Technology S.A.'s patents?

Loewenstein Medical Technology S.A.'s patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Loewenstein Medical Technology S.A. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Loewenstein Medical Technology S.A.

Q: What technology areas does Loewenstein Medical Technology S.A. focus on?

Loewenstein Medical Technology S.A.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 73 patents, ranking #104 of 3,490 assignees active in that subclass. Grants appear in 24 CPC subclasses total.

USPTO PatentsView assignee record - 77 granted patents across 24 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Loewenstein ranks #4,568 of 49,997 tracked US assignees by granted-patent volume, with 77 patents across 24 technology areas.

#4,568
of 49,997 US assignees by volume: Top 4%
by Innovation Score (58.6/100): 19.0
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4568 · Foreign Corporation #4,568 · 77 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 77 grants
TOP-DECILE #4,568/49,997
PHOTO-FINISH Idorsia Pharmaceutic…
CPC-FOCUS A61M · 24 areas
INNOV-PAR 58.6/100
CLAIMS-RICH 19.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Idorsia Pharmaceuticals Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Loewenstein’s 58.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.0 pts (26%) Velocity 14.8 pts (25%) Breadth 17.3 pts (30%) Claim depth 11.4 pts (19%)

Qualcomm Incorporated · highest

85
Brelyon · near

59
Champion Link… · near

59
Loewenstein Medical… · this assignee

59
SMA Solar Technology · near

59
Toyota Jidoshokki · near

59
3D Lighting… · lowest

7

What this shows Loewenstein's Innovation Score is 58.6/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Loewenstein?

Each dot is one of Loewenstein’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Loewenstein’s own 19.0 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Loewenstein vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Loewenstein's grants concentrate

Loewenstein Medical Technology S.A. is a focused PatentsView assignee: 24 CPC subclasses with 94.8% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (15 grants) versus a trough of 3 in 2017. By volume, Loewenstein sits between Idorsia Pharmaceuticals Ltd and Mie Fujitsu Semiconductor Limited.

Loewenstein's three-year grant acceleration

Loewenstein Medical Technology S.A. shows 40 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Idorsia Pharmaceu…

77
Isis Innovation

77
J S T MFG

77
L3

77
Lighting Science…

77
Meiji

77
Matterport

77
Mie Fujitsu Semic…

77
Loewenstein Medic… ◀

77

What this shows Loewenstein holds 77 patents at rank #4,567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Loewenstein

By rank, the assignees closest to #4,567 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Loewenstein's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Loewenstein, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Loewenstein ranks #104 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

SMA Solar Technology AG 59 Champion Link International Corporation 59 Kabushiki Kaisha Toyota Jidoshokki 59 Brelyon Inc 59

Similar claim depth

Nearest assignees by average claims per patent (19.0 here).

LOS Alamos National Security, LLC 19.0 avg Mako Surgical Corp. 19.0 avg Datalogic USA, Inc. 19.0 avg Smule, Inc. 19.0 avg

Loewenstein's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Loewenstein Medical Technology S.A. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	3.9%
2018	4	5.2%
2019	6	7.8%
2020	4	5.2%
2021	8	10.4%
2022	11	14.3%
2023	14	18.2%
2024	15	19.5%
2025partial year	12	15.6%

Which technologies does Loewenstein Medical Technology S.A. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 73

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 21

A61B - DIAGNOSIS; SURGERY; Identification 16

G06F - Electric Digital Data Processing 12

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 8

H04W - Wireless Communication Networks 5

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 3

Y10T - Technical Subjects Covered BY Former US Classification 3

G06T - Image Data Processing OR Generation, IN General 2

A62B - Devices, Apparatus OR Methods FOR Life-saving 2

F16F - SPRINGS; SHOCK-ABSORBERS; Means FOR Damping Vibration 2

F04D - Non-positive-displacement Pumps 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Y02C - Capture, Storage, Sequestration OR Disposal OF Greenhouse Gases [GHG] 1

B01D - Separation 1

Top 15 of 24 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Loewenstein Medical Technology S.A.'s patent record in context - here's where to go next.

Loewenstein Medical Technology S.A.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 94.8% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #4,568 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Loewenstein Medical Technology S.A. against Idorsia Pharmaceuticals Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 58.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.